Cover Image

mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors

Objective: - The aim of this study was to evaluate the survival benefit of sirolimus in patients undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC) (exploratory analysis of the SiLVER-trial). - Summary and Background Data: - Patients receiving LT) for...

Full description

Saved in:
Bibliographic Details
Main Authors: Schnitzbauer, Andreas (Author) , Filmann, Natalie (Author) , Adam, René (Author) , Bachellier, Philippe (Author) , Bechstein, Wolf Otto (Author) , Becker, Thomas (Author) , Bhoori, Sherrie (Author) , Bilbao, Itxarone (Author) , Brockmann, Jens (Author) , Burra, Patrizia (Author) , Chazoullières, Olivier (Author) , Cillo, Umberto (Author) , Colledan, Michele (Author) , Duvoux, Christoph (Author) , Ganten, Tom M. (Author) , Gugenheim, Jean (Author) , Heise, Michael (Author) , Hoek, Bart van (Author) , Jamieson, Neville (Author) , de Jong, Koert P. (Author) , Klein, Christian G. (Author) , Klempnauer, Jürgen (Author) , Kneteman, Norman (Author) , Lerut, Jan (Author) , Mäkisalo, Heikki (Author) , Mazzaferro, Vincenzo (Author) , Mirza, Darius F. (Author) , Nadalin, Silvio (Author) , Neuhaus, Peter (Author) , Pageaux, George-Philippe (Author) , Pinna, Antonio D. (Author) , Pirenne, Jaques (Author) , Pratschke, Johann (Author) , Powel, James (Author) , Rentsch, Markus (Author) , Rizell, Magnus (Author) , Rossi, Giorgio (Author) , Rostaing, Lionel (Author) , Roy, André (Author) , Scholz, Tim (Author) , Settmacher, Utz (Author) , Soliman, Thomas (Author) , Strasser, Simone (Author) , Söderdahl, Gunnar (Author) , Troisi, Roberto I. (Author) , Turrión, Victor Sánchez (Author) , Schlitt, Hans Jürgen (Author) , Geissler, Edward K. (Author)
Format: Article (Journal)
Language:English
Published: September 3, 2020
In: Annals of surgery
Year: 2020, Volume: 272, Issue: 5, Pages: 855-862
ISSN:1528-1140
DOI:10.1097/SLA.0000000000004280
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/SLA.0000000000004280
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/annalsofsurgery/Fulltext/2020/11000/mTOR_Inhibition_Is_Most_Beneficial_After_Liver.28.aspx
Get full text
Author Notes:Andreas A. Schnitzbauer, MD, Natalie Filmann, PhD, Rene Adam, MD, Philippe Bachellier, MD, Wolf O. Bechstein, MD, Thomas Becker, MD, Sherrie Bhoori, MD, Itxarone Bilbao, MD, Jens Brockmann, MD, Patrizia Burra, MD, Olivier Chazoullieres, MD, Umberto Cillo, MD, Michele Colledan, MD, Christoph Duvoux, MD, Tom M. Ganten, MD, Jean Gugenheim, MD, Michael Heise, MD, Bart van Hoek, MD, Neville Jamieson, MD, Koert P. de Jong, MD, Christian G. Klein, MD, Jürgen Klempnauer, MD, Norman Kneteman, MD, Jan Lerut, MD, Heikki Makisalo, MD, Vincenzo Mazzaferro, MD, Darius F. Mirza, MD, Silvio Nadalin, MD, Peter Neuhaus, MD, George-Philippe Pageaux, MD, Antonio D. Pinna, MD, Jaques Pirenne, MD, Johann Pratschke, MD, James Powel, MD, Markus Rentsch, MD, Magnus Rizell, MD, Giorgio Rossi, MD, Lionel Rostaing, MD, Andre Roy, MD, Tim Scholz, MD, Utz Settmacher, MD, Thomas Soliman, MD, Simone Strasser, MD, Gunnar Söderdahl, MD, Roberto I. Troisi, MD, Victor Sanchez Turrion, MD, Hans J. Schlitt, MD, and Edward K. Geissler, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1751422852
003 DE-627
005 20240412193315.0
007 cr uuu---uuuuu
008 210316s2020 xx |||||o 00| ||eng c
024 7 |a 10.1097/SLA.0000000000004280  |2 doi 
035 |a (DE-627)1751422852 
035 |a (DE-599)KXP1751422852 
035 |a (OCoLC)1341398908 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schnitzbauer, Andreas  |d 1976-  |e VerfasserIn  |0 (DE-588)130002917  |0 (DE-627)486917533  |0 (DE-576)297944754  |4 aut 
245 1 0 |a mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors  |c Andreas A. Schnitzbauer, MD, Natalie Filmann, PhD, Rene Adam, MD, Philippe Bachellier, MD, Wolf O. Bechstein, MD, Thomas Becker, MD, Sherrie Bhoori, MD, Itxarone Bilbao, MD, Jens Brockmann, MD, Patrizia Burra, MD, Olivier Chazoullieres, MD, Umberto Cillo, MD, Michele Colledan, MD, Christoph Duvoux, MD, Tom M. Ganten, MD, Jean Gugenheim, MD, Michael Heise, MD, Bart van Hoek, MD, Neville Jamieson, MD, Koert P. de Jong, MD, Christian G. Klein, MD, Jürgen Klempnauer, MD, Norman Kneteman, MD, Jan Lerut, MD, Heikki Makisalo, MD, Vincenzo Mazzaferro, MD, Darius F. Mirza, MD, Silvio Nadalin, MD, Peter Neuhaus, MD, George-Philippe Pageaux, MD, Antonio D. Pinna, MD, Jaques Pirenne, MD, Johann Pratschke, MD, James Powel, MD, Markus Rentsch, MD, Magnus Rizell, MD, Giorgio Rossi, MD, Lionel Rostaing, MD, Andre Roy, MD, Tim Scholz, MD, Utz Settmacher, MD, Thomas Soliman, MD, Simone Strasser, MD, Gunnar Söderdahl, MD, Roberto I. Troisi, MD, Victor Sanchez Turrion, MD, Hans J. Schlitt, MD, and Edward K. Geissler, PhD 
264 1 |c September 3, 2020 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.03.2021 
520 |a Objective: - The aim of this study was to evaluate the survival benefit of sirolimus in patients undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC) (exploratory analysis of the SiLVER-trial). - Summary and Background Data: - Patients receiving LT) for HCC are at a high risk for tumor recurrence. Calcineurin inhibitors have shown evidence to promote cancer growth, whereas mammalian target of rapamycin (mTOR) inhibitors like sirolimus have anticancer effects. In the SiLVER-trial (Clinicaltrials.gov: NCT00355862), the effect of sirolimus on the recurrence of HCC after LT was investigated in a prospective randomized trial. Although the primary endpoint of improved disease-free survival (DFS) with sirolimus was not met, outcomes were improved for patients in the sirolimus-treatment arm in the first 3 to 5 years. To learn more about the key variables, a multivariate analysis was performed on the SiLVER-trial data. - Patients and Methods: - Data from 508 patients of the intention-to-treat analysis were included in exploratory univariate and multivariate models for overall survival (OS), DFS and a competing risk analysis for HCC recurrence. - Results: - Sirolimus use for ≥3 months after LT for HCC independently reduced the hazard for death in the multivariate analysis [hazard ratio (HR): 0.7 (95% confidence interval, CI: 0.52-0.96, P = 0.02). Most strikingly, patients with an alpha-fetoprotein (AFP) ≥10 ng/mL and having used sirolimus for ≥3 months, benefited most with regard to OS, DFS, and HCC-recurrence (HR: 0.49-0.59, P = 0.0079-0.0245). - Conclusions: - mTOR-inhibitor treatment with sirolimus for ≥3 months improves outcomes in LT for HCC, especially in patients with AFP-evidence of higher tumor activity, advocating particularly for mTOR inhibitor use in this subgroup of patients. - Clinical Trial Registration: - EudraCT: 2005-005362-36 - Clinicaltrials.gov: - NCT00355862. 
700 1 |a Filmann, Natalie  |e VerfasserIn  |4 aut 
700 1 |a Adam, René  |e VerfasserIn  |4 aut 
700 1 |a Bachellier, Philippe  |e VerfasserIn  |4 aut 
700 1 |a Bechstein, Wolf Otto  |d 1958-  |e VerfasserIn  |0 (DE-588)11063151X  |0 (DE-627)611802333  |0 (DE-576)312301863  |4 aut 
700 1 |a Becker, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Bhoori, Sherrie  |e VerfasserIn  |4 aut 
700 1 |a Bilbao, Itxarone  |e VerfasserIn  |4 aut 
700 1 |a Brockmann, Jens  |e VerfasserIn  |4 aut 
700 1 |a Burra, Patrizia  |e VerfasserIn  |4 aut 
700 1 |a Chazoullières, Olivier  |e VerfasserIn  |4 aut 
700 1 |a Cillo, Umberto  |e VerfasserIn  |4 aut 
700 1 |a Colledan, Michele  |e VerfasserIn  |4 aut 
700 1 |a Duvoux, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Ganten, Tom M.  |d 1969-  |e VerfasserIn  |0 (DE-588)115539670  |0 (DE-627)69139010X  |0 (DE-576)289938899  |4 aut 
700 1 |a Gugenheim, Jean  |e VerfasserIn  |4 aut 
700 1 |a Heise, Michael  |e VerfasserIn  |4 aut 
700 1 |a Hoek, Bart van  |d 1956-  |e VerfasserIn  |0 (DE-588)17353273X  |0 (DE-627)698444612  |0 (DE-576)134377273  |4 aut 
700 1 |a Jamieson, Neville  |e VerfasserIn  |4 aut 
700 1 |a de Jong, Koert P.  |e VerfasserIn  |4 aut 
700 1 |a Klein, Christian G.  |e VerfasserIn  |4 aut 
700 1 |a Klempnauer, Jürgen  |e VerfasserIn  |0 (DE-588)120197871  |0 (DE-627)080515347  |0 (DE-576)292091125  |4 aut 
700 1 |a Kneteman, Norman  |e VerfasserIn  |4 aut 
700 1 |a Lerut, Jan  |e VerfasserIn  |4 aut 
700 1 |a Mäkisalo, Heikki  |e VerfasserIn  |4 aut 
700 1 |a Mazzaferro, Vincenzo  |e VerfasserIn  |4 aut 
700 1 |a Mirza, Darius F.  |e VerfasserIn  |4 aut 
700 1 |a Nadalin, Silvio  |e VerfasserIn  |0 (DE-588)1016002343  |0 (DE-627)671218166  |0 (DE-576)351395431  |4 aut 
700 1 |a Neuhaus, Peter  |e VerfasserIn  |4 aut 
700 1 |a Pageaux, George-Philippe  |e VerfasserIn  |4 aut 
700 1 |a Pinna, Antonio D.  |e VerfasserIn  |4 aut 
700 1 |a Pirenne, Jaques  |e VerfasserIn  |4 aut 
700 1 |a Pratschke, Johann  |d 1965-  |e VerfasserIn  |0 (DE-588)115663827  |0 (DE-627)077392337  |0 (DE-576)290007097  |4 aut 
700 1 |a Powel, James  |e VerfasserIn  |4 aut 
700 1 |a Rentsch, Markus  |e VerfasserIn  |4 aut 
700 1 |a Rizell, Magnus  |e VerfasserIn  |4 aut 
700 1 |a Rossi, Giorgio  |d 1952-  |e VerfasserIn  |0 (DE-588)131610228  |0 (DE-627)707681030  |0 (DE-576)298623102  |4 aut 
700 1 |a Rostaing, Lionel  |e VerfasserIn  |4 aut 
700 1 |a Roy, André  |e VerfasserIn  |4 aut 
700 1 |a Scholz, Tim  |e VerfasserIn  |4 aut 
700 1 |a Settmacher, Utz  |d 1963-  |e VerfasserIn  |0 (DE-588)172370469  |0 (DE-627)704727331  |0 (DE-576)36205522X  |4 aut 
700 1 |a Soliman, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Strasser, Simone  |e VerfasserIn  |4 aut 
700 1 |a Söderdahl, Gunnar  |e VerfasserIn  |4 aut 
700 1 |a Troisi, Roberto I.  |e VerfasserIn  |4 aut 
700 1 |a Turrión, Victor Sánchez  |e VerfasserIn  |4 aut 
700 1 |a Schlitt, Hans Jürgen  |d 1961-  |e VerfasserIn  |0 (DE-588)111528836  |0 (DE-627)516471864  |0 (DE-576)289705207  |4 aut 
700 1 |a Geissler, Edward K.  |e VerfasserIn  |0 (DE-588)1208657208  |0 (DE-627)1694995364  |4 aut 
773 0 8 |i Enthalten in  |t Annals of surgery  |d [Erscheinungsort nicht ermittelbar] : Lippincott Williams & Wilkins, 1885  |g 272(2020), 5, Seite 855-862  |h Online-Ressource  |w (DE-627)313115222  |w (DE-600)2002200-1  |w (DE-576)090881796  |x 1528-1140  |7 nnas  |a mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors 
773 1 8 |g volume:272  |g year:2020  |g number:5  |g pages:855-862  |g extent:8  |a mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors 
856 4 0 |u https://doi.org/10.1097/SLA.0000000000004280  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.lww.com/annalsofsurgery/Fulltext/2020/11000/mTOR_Inhibition_Is_Most_Beneficial_After_Liver.28.aspx  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210316 
993 |a Article 
994 |a 2020 
998 |g 115539670  |a Ganten, Tom M.  |m 115539670:Ganten, Tom M.  |d 50000  |e 50000PG115539670  |k 0/50000/  |p 15 
999 |a KXP-PPN1751422852  |e 3889143482 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"8 S."}],"relHost":[{"id":{"eki":["313115222"],"zdb":["2002200-1"],"issn":["1528-1140"]},"origin":[{"publisherPlace":"[Erscheinungsort nicht ermittelbar] ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1885-","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1885"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Annals of surgery","title":"Annals of surgery","subtitle":"a monthly review of surgical science and practice"}],"language":["eng"],"recId":"313115222","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumorsAnnals of surgery","note":["Gesehen am 26.09.18"],"part":{"extent":"8","volume":"272","text":"272(2020), 5, Seite 855-862","pages":"855-862","issue":"5","year":"2020"},"pubHistory":["1.1885 -"]}],"origin":[{"dateIssuedDisp":"September 3, 2020","dateIssuedKey":"2020"}],"id":{"eki":["1751422852"],"doi":["10.1097/SLA.0000000000004280"]},"name":{"displayForm":["Andreas A. Schnitzbauer, MD, Natalie Filmann, PhD, Rene Adam, MD, Philippe Bachellier, MD, Wolf O. Bechstein, MD, Thomas Becker, MD, Sherrie Bhoori, MD, Itxarone Bilbao, MD, Jens Brockmann, MD, Patrizia Burra, MD, Olivier Chazoullieres, MD, Umberto Cillo, MD, Michele Colledan, MD, Christoph Duvoux, MD, Tom M. Ganten, MD, Jean Gugenheim, MD, Michael Heise, MD, Bart van Hoek, MD, Neville Jamieson, MD, Koert P. de Jong, MD, Christian G. Klein, MD, Jürgen Klempnauer, MD, Norman Kneteman, MD, Jan Lerut, MD, Heikki Makisalo, MD, Vincenzo Mazzaferro, MD, Darius F. Mirza, MD, Silvio Nadalin, MD, Peter Neuhaus, MD, George-Philippe Pageaux, MD, Antonio D. Pinna, MD, Jaques Pirenne, MD, Johann Pratschke, MD, James Powel, MD, Markus Rentsch, MD, Magnus Rizell, MD, Giorgio Rossi, MD, Lionel Rostaing, MD, Andre Roy, MD, Tim Scholz, MD, Utz Settmacher, MD, Thomas Soliman, MD, Simone Strasser, MD, Gunnar Söderdahl, MD, Roberto I. Troisi, MD, Victor Sanchez Turrion, MD, Hans J. Schlitt, MD, and Edward K. Geissler, PhD"]},"note":["Gesehen am 16.03.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1751422852","language":["eng"],"title":[{"title":"mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors","title_sort":"mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Schnitzbauer, Andreas","given":"Andreas","family":"Schnitzbauer"},{"family":"Filmann","given":"Natalie","display":"Filmann, Natalie","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Adam, René","role":"aut","family":"Adam","given":"René"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Bachellier, Philippe","given":"Philippe","family":"Bachellier"},{"role":"aut","display":"Bechstein, Wolf Otto","roleDisplay":"VerfasserIn","given":"Wolf Otto","family":"Bechstein"},{"display":"Becker, Thomas","roleDisplay":"VerfasserIn","role":"aut","family":"Becker","given":"Thomas"},{"display":"Bhoori, Sherrie","roleDisplay":"VerfasserIn","role":"aut","family":"Bhoori","given":"Sherrie"},{"display":"Bilbao, Itxarone","roleDisplay":"VerfasserIn","role":"aut","family":"Bilbao","given":"Itxarone"},{"family":"Brockmann","given":"Jens","display":"Brockmann, Jens","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Burra","given":"Patrizia","roleDisplay":"VerfasserIn","display":"Burra, Patrizia","role":"aut"},{"family":"Chazoullières","given":"Olivier","roleDisplay":"VerfasserIn","display":"Chazoullières, Olivier","role":"aut"},{"display":"Cillo, Umberto","roleDisplay":"VerfasserIn","role":"aut","family":"Cillo","given":"Umberto"},{"given":"Michele","family":"Colledan","role":"aut","roleDisplay":"VerfasserIn","display":"Colledan, Michele"},{"given":"Christoph","family":"Duvoux","role":"aut","display":"Duvoux, Christoph","roleDisplay":"VerfasserIn"},{"family":"Ganten","given":"Tom M.","roleDisplay":"VerfasserIn","display":"Ganten, Tom M.","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Gugenheim, Jean","role":"aut","family":"Gugenheim","given":"Jean"},{"roleDisplay":"VerfasserIn","display":"Heise, Michael","role":"aut","family":"Heise","given":"Michael"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Hoek, Bart van","given":"Bart van","family":"Hoek"},{"given":"Neville","family":"Jamieson","role":"aut","display":"Jamieson, Neville","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"de Jong, Koert P.","given":"Koert P.","family":"de Jong"},{"display":"Klein, Christian G.","roleDisplay":"VerfasserIn","role":"aut","family":"Klein","given":"Christian G."},{"display":"Klempnauer, Jürgen","roleDisplay":"VerfasserIn","role":"aut","family":"Klempnauer","given":"Jürgen"},{"given":"Norman","family":"Kneteman","role":"aut","display":"Kneteman, Norman","roleDisplay":"VerfasserIn"},{"given":"Jan","family":"Lerut","role":"aut","display":"Lerut, Jan","roleDisplay":"VerfasserIn"},{"given":"Heikki","family":"Mäkisalo","role":"aut","roleDisplay":"VerfasserIn","display":"Mäkisalo, Heikki"},{"given":"Vincenzo","family":"Mazzaferro","role":"aut","roleDisplay":"VerfasserIn","display":"Mazzaferro, Vincenzo"},{"family":"Mirza","given":"Darius F.","roleDisplay":"VerfasserIn","display":"Mirza, Darius F.","role":"aut"},{"family":"Nadalin","given":"Silvio","roleDisplay":"VerfasserIn","display":"Nadalin, Silvio","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Neuhaus, Peter","role":"aut","family":"Neuhaus","given":"Peter"},{"display":"Pageaux, George-Philippe","roleDisplay":"VerfasserIn","role":"aut","family":"Pageaux","given":"George-Philippe"},{"family":"Pinna","given":"Antonio D.","display":"Pinna, Antonio D.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Pirenne, Jaques","roleDisplay":"VerfasserIn","given":"Jaques","family":"Pirenne"},{"family":"Pratschke","given":"Johann","roleDisplay":"VerfasserIn","display":"Pratschke, Johann","role":"aut"},{"given":"James","family":"Powel","role":"aut","display":"Powel, James","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Rentsch, Markus","role":"aut","family":"Rentsch","given":"Markus"},{"roleDisplay":"VerfasserIn","display":"Rizell, Magnus","role":"aut","family":"Rizell","given":"Magnus"},{"given":"Giorgio","family":"Rossi","role":"aut","display":"Rossi, Giorgio","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Rostaing, Lionel","roleDisplay":"VerfasserIn","given":"Lionel","family":"Rostaing"},{"family":"Roy","given":"André","roleDisplay":"VerfasserIn","display":"Roy, André","role":"aut"},{"role":"aut","display":"Scholz, Tim","roleDisplay":"VerfasserIn","given":"Tim","family":"Scholz"},{"display":"Settmacher, Utz","roleDisplay":"VerfasserIn","role":"aut","family":"Settmacher","given":"Utz"},{"display":"Soliman, Thomas","roleDisplay":"VerfasserIn","role":"aut","family":"Soliman","given":"Thomas"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Strasser, Simone","given":"Simone","family":"Strasser"},{"role":"aut","display":"Söderdahl, Gunnar","roleDisplay":"VerfasserIn","given":"Gunnar","family":"Söderdahl"},{"display":"Troisi, Roberto I.","roleDisplay":"VerfasserIn","role":"aut","family":"Troisi","given":"Roberto I."},{"family":"Turrión","given":"Victor Sánchez","roleDisplay":"VerfasserIn","display":"Turrión, Victor Sánchez","role":"aut"},{"given":"Hans Jürgen","family":"Schlitt","role":"aut","roleDisplay":"VerfasserIn","display":"Schlitt, Hans Jürgen"},{"roleDisplay":"VerfasserIn","display":"Geissler, Edward K.","role":"aut","family":"Geissler","given":"Edward K."}]} 
SRT |a SCHNITZBAUMTORINHIBI3202 

Similar Items